Web Analytics

3 Latest Announced Rounds

  • $4,200,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jun 5th, 2025
  • $9,142,230
    Seed

    1 Investors

    Software Development
    Jun 5th, 2025
  • $25,000,000
    Unknown

    2 Investors

    Software Development
    Jun 5th, 2025
$883.17M Raised in 51 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Myeloid Therapeutics

start up
United States - Cambridge, Massachusetts
  • 19/05/2023
  • Unknown
  • $73,000,000

At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies that harness the innate abilities of myeloid cells. We have translated the learnings from our backgrounds and novel platform to create a clinical-stage, mRNA-immunotherapy pipeline focused on breakthrough therapies for cancer.

We invite you to join us on this journey – patients are waiting.


Related People

Daniel G.Co Founder

Daniel G. United States - Greater Boston

Dr Getts is a repeat inventor, company co-founder and builder. He is currently the Chief Executive Officer & co-founder of Myeloid Therapeutics Inc .